Who owns CARISMA THERAPEUTICS INC?
- Ticker: CARM
- CUSIP Number: 14216r101
Tip: Access positions for across all investors
Analyze quarterly positions in Carisma Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Carisma Therapeutics stock
Who bought or sold CARISMA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Tpg Gp A | 1.7M | $4.9M | 0% | Dec 2023 |
|
| Vanguard Group | 1.6M | $4.6M | 1% | Dec 2023 |
|
| Bank of New York Mellon | 84k | $245k | 0% | Dec 2023 |
|
| Charles Schwab Investment Management | 73k | $213k | 0% | Dec 2023 |
|
| Arrowstreet Capital, Limited Partnership | 46k | $135k | -74% | Dec 2023 |
|
| Bank of America Corporation | 44k | $128k | -20% | Dec 2023 |
|
| Barclays | 37k | $107k | 651% | Dec 2023 |
|
| Rhumbline Advisers | 34k | $101k | 0% | Dec 2023 |
|
| UBS Group | 30k | $86k | 99% | Dec 2023 |
|
| Dimensional Fund Advisors | 28k | $82k | -8% | Dec 2023 |
|
| Blodgett Wealth Advisors | 26k | $75k | 0% | Dec 2023 |
|
| Two Sigma Investments | 25k | $74k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 18k | $52k | 0% | Dec 2023 |
|
| SG Americas Securities | 15k | $43k | 7% | Dec 2023 |
|
| American International | 13k | $39k | 0% | Dec 2023 |
|
| Stratos Wealth Partners | 13k | $29k | 100% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 12k | $36k | 0% | Dec 2023 |
|
| Goldman Sachs Group | 11k | $31k | -17% | Dec 2023 |
|
| Wolverine Trading | 10k | $30k | 0% | Dec 2023 |
|
| Royal Bank of Canada | 8.5k | $24k | 90% | Dec 2023 |
|
| Wells Fargo & Company | 8.2k | $24k | 17% | Dec 2023 |
|
| Citigroup | 3.8k | $11k | 29246% | Dec 2023 |
|
| New York State Common Retirement Fund | 2.4k | $7.0k | -4% | Dec 2023 |
|
| Amalgamated Bank | 2.3k | $7.0k | -10% | Dec 2023 |
|
| Summit Investment Advisors | 2.2k | $6.5k | 0% | Dec 2023 |
|
| Legal & General Group | 2.2k | $6.3k | 0% | Dec 2023 |
|
| Cutler | 705.00 | $0 | 0% | Dec 2023 |
|
| Peoples Bank | 250.00 | $565.000000 | 0% | Mar 2024 |
|
| IFP Advisors | 206.00 | $603.003200 | 0% | Dec 2023 |
|
| ORG Partners | 200.00 | $586.000000 | 0% | Dec 2023 |
|
| Ancora Advisors | 65.00 | $190.001500 | 0% | Dec 2023 |
|
| National Bank Of Canada /fi/ | 50.00 | $142.000000 | 0% | Dec 2023 |
|
| Deuterium Capital Management | 30.00 | $155.001000 | 100% | Dec 2023 |
|
| Advisor Group Holdings | 25.00 | $73.000000 | 0% | Dec 2023 |
|
| Signature Resources Capital Management | 14.00 | $41.000400 | 0% | Mar 2024 |
|
| CWM | 4.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Carisma Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Wellington Management Company | Sep 2023 | 66k | $279k |
| Jane Street | Sep 2023 | 36k | $154k |
| Mirae Asset Global Investments | Sep 2023 | 14k | $60k |
| MetLife Investment Advisors | Sep 2023 | 14k | $60k |
| Hussman Econometrics Advisors | Sep 2023 | 5.3k | $22k |
| Metropolitan Life Insurance Company | Sep 2023 | 1.5k | $6.2k |